SL McAfee
Impact in
- Hematology top 10%
- Hematopoietic Stem Cell Transplantation
-
- Neutropenia and Cancer Infections
- Cancer survivorship and care
Papers in
- Hematology 11
- Hematopoietic Stem Cell Transplantation 11
- Oncology 2
- Cancer survivorship and care 2
- Co-authors
- Christine Colby (7 shared papers)TR Spitzer (4 shared papers)Robert Sackstein (4 shared papers)Jay A. Fishman (1 shared paper)Thomas R. Spitzer (6 shared papers)B Dey (6 shared papers)Karen Kuhn Ballen (5 shared papers)B.Y. Yeap (1 shared paper)
- Journals
- Bone Marrow Transplantation (9 papers)Transplantation and Cellular Therapy (1 paper)Gynecologic Oncology (1 paper)PubMed (2 papers)
- Partner nations
- United States
In The Last Decade
SL McAfee
14 papers receiving 344 citations
Peers
Comparison fields: 5 of 52
- Hematology 158
- Oncology 57
- Epidemiology 47
- Public Health, Environmental and Occupational Health 45
- Pharmacy 5
Countries citing papers authored by SL McAfee
This map shows the geographic impact of SL McAfee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by SL McAfee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites SL McAfee more than expected).
Fields of papers citing papers by SL McAfee
This network shows the impact of papers produced by SL McAfee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by SL McAfee. The network helps show where SL McAfee may publish in the future.
Co-authors
The 25 scholars most cited alongside SL McAfee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 84 | |
| 2 | 2015 | 70 | |
| 3 | 1999 | 59 | |
| 4 | 2012 | 27 | |
| 5 | Phase I-II trial of high-dose cyclophosphamide, carboplatin and autologous bone marrow or peripheral blood stem cell rescue. | 1995 | 26 |
| 6 | 1998 | 22 | |
| 7 | 2002 | 20 | |
| 8 | 2000 | 12 | |
| 9 | 2008 | 12 | |
| 10 | Achievement of sustained remissions despite loss of donor chimerism in patients with chemotherapy-refractory non-Hodgkins lymphoma treated with nonmyeloablative conditioning and allogeneic stem cell transplantation | 2001 | 7 |
| 11 | 2008 | 6 | |
| 12 | 2001 | 5 | |
| 13 | Methods of stem cell mobilization. | 1996 | 3 |
| 14 | 2012 | 2 |
About SL McAfee
SL McAfee is a scholar working on Hematology, Oncology, Reproductive Medicine, Public Health, Environmental and Occupational Health and Statistics and Probability, having authored 14 papers that have together received 355 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (11 papers), Cancer survivorship and care (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (1 paper), Ovarian cancer diagnosis and treatment (1 paper), Lymphoma Diagnosis and Treatment (1 paper), Statistical Methods in Clinical Trials (1 paper), Organ Transplantation Techniques and Outcomes (1 paper) and Breast Cancer Treatment Studies (1 paper). The work is most often cited by research in Hematology (158 citations), Oncology (57 citations), Epidemiology (47 citations), Public Health, Environmental and Occupational Health (45 citations) and Pharmacy (5 citations). SL McAfee has collaborated with scholars based in United States. Frequent co-authors include Christine Colby, TR Spitzer, Robert Sackstein, Jay A. Fishman, Thomas R. Spitzer, B Dey, Karen Kuhn Ballen, B.Y. Yeap, Justin R. Eusebio and Tanya Elizabeth Keenan. Their work appears in journals such as Bone Marrow Transplantation, Transplantation and Cellular Therapy, Gynecologic Oncology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.